Journal Finder

Computational and Structural Biotechnology Journal (CSBJ) is an online journal publishing research articles and reviews after full peer review. All articles are published, without barriers to access, immediately upon acceptance. The journal places a strong emphasis on functional and mechanistic understanding of how molecular components in a biological process work together through the application of computational methods. Structural data may provide such insights, but they are not a pre-requisite for publication in the journal. Specific areas of interest include, but are not limited to:

• Structure and function of proteins, nucleic acids and other macromolecules
• Structure and function of multi-component complexes
• Protein folding, processing and degradation
• Enzymology
• Computational and structural studies of plant systems
• Microbial Informatics
• Genomics
• Proteomics
• Metabolomics
• Algorithms and Hypothesis in Bioinformatics
• Mathematical and Theoretical Biology
• Computational Chemistry and Drug Discovery
• Microscopy and Molecular Imaging
• Nanotechnology
• Systems and Synthetic Biology

While all general topics related to Computational and Structural Biology are welcomed, the editors reserve the right to pre-screen submissions based on the suitability of the topic of a submission and, therefore, the right as whether a manuscript will be processed/reviewed or not. Even though experimental validation is not required for publication, reliability and significance of biological discovery are validated and enriched by experimental studies.

The journal welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence, and enables the rapid publication of papers under the following categories:

• Research articles
• Review articles
• Mini Reviews
• Highlights
• Communications
• Software/Web server articles
• Methods articles
• Database articles
• Book Reviews
• Meeting Reviews

Current Biotechnology publishes critical and authoritative reviews, original research and methodology articles, and thematic issues in all areas of biotechnology, including basic and applied research. The journal serves as an advanced forum for innovative studies and major trends at the interface of technology, life sciences and biomedicine. Our aim is to provide a comprehensive and reliable source of information on the current advances and future perspectives in key themes of biotechnology.

Current Nanoscience publishes (a) Authoritative/Mini Reviews, and (b) Original Research and Highlights written by experts covering the most recent advances in nanoscience and nanotechnology. All aspects of the field are represented including nano-structures, nano-bubbles, nano-droplets and nanofluids. Applications of nanoscience in physics, material science, chemistry, synthesis, environmental science, electronics, biomedical nanotechnology, biomedical engineering, biotechnology, medicine and pharmaceuticals are also covered. The journal is essential to all researches involved in nanoscience and its applied and fundamental areas of science, chemistry, physics, material science, engineering and medicine.

The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In Current Opinion in Biotechnology, we help the reader by providing in a systematic manner:1. The views of experts on current advances in biotechnology in a clear and readable form.2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Division of the subject into sectionsThe subject of biotechnology is divided into themed sections, each of which is reviewed once a year. The amount of space devoted to each section is related to its importance.Analytical biotechnology • Plant biotechnology • Food biotechnology • Energy biotechnology • Environmental biotechnology • Systems biology • Nanobiotechnology • Tissue, cell and pathway engineering • Chemical biotechnology • Pharmaceutical biotechnologySelection of topics to be reviewedSection Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.ReviewsAuthors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.Editorial OverviewSection Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.This successful format has made Current Opinion in Biotechnology one of the most highly regarded and highly cited review journals in the field (Impact factor = 7.711).Ethics in Publishing: General StatementThe Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews, research articles and letters written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Current Proteomics publishes in-depth/mini review articles in all aspects of the fast-expanding field of proteomics. All areas of proteomics are covered together with the methodology, software, databases, technological advances and applications of proteomics, including functional proteomics.

Cytotechnology incorporating Methods in Cell Science is an international journal covering up-to-date developments, methods and techniques in cell culture research involving in vitro systems, as well as the applications of that research in human and veterinary medicine, toxicology, animal and plant cell biotechnology. The aim is to centralize information on both the infrastructure of cell technology and the applied use of cell cultures and thus generate a better understanding of the many facets and disciplines needed to develop successful cell culture processes. Topics include the derivation, genetic modification and characterization of cell lines, cell culture techniques, cell culture systems, processes, reactors, scale-up, and industrial production, and the application of cells in a range of investigations, including application in gene therapy and tissue engineering. The journal publishes original papers, reviews, short communications, meeting reports and book reviews.

The Drug Discovery Today reviews collection provides a resource of review content aligning the key output of human molecular medicine with the specific requirements of the drug discovery process. It is designed to systematically cover the essential elements of molecular medicine and drug discovery, in a manner that has relevance to those actually working on the discovery and development of new drugs. This collection will evolve to create a highly structured database and will act as a one-stop-shop for high quality content.

The journal provides an effective way to publish research and review articles, short communications and technical notes, Video material, animation sequences and 3D are also accepted to support and enhance articles. The articles will be examined by a scientific committee and anonymous evaluators and published every two months in HTML and PDF formats (January 15th , March 15th, May 15th, July 15th, September 15th, November 15th).

The following areas are covered in the Journal:
• Animal Biotechnology
• Bioethics
• Biofilms
• Bioinformatics
• Biopolicies of International Cooperation
• Biosafety
• Biotechnology Industry
• Biotechnology of Human Disorders
• Chemical Engineering
• Environmental Biotechnology
• Food Biotechnology
• Marine Biotechnology
• Medical Biotechnology
• Microbial Biotechnology
• Molecular Biology and Genetics
• Plant Biotechnology
• Process Biotechnology
• Process Chemistry and Technology

Electronic Journal of Biotechnology is a http://publicationethics.org/members/peerjfull Member of the Committee on Publication Ethics (http://publicationethics.org/COPE).

Energy & Environmental Science is an international journal dedicated to publishing exceptionally important and high quality, agenda-setting research tackling the key global and societal challenges of ensuring the provision of energy and protecting our environment for the future. The scope is intentionally broad and the journal recognises the complexity of issues and challenges relating to energy conversion and storage, alternative fuel technologies and environmental science. For work to be published it must be linked to the energy-environment nexus and be of significant general interest to our community-spanning readership. All scales of studies and analysis, from impactful fundamental advances, to interdisciplinary research across the (bio)chemical, (bio/geo)physical sciences and chemical engineering disciplines are welcomed.

Engineering in Life Sciences covers all technological aspects of Industrial, Environmental, Plant and Food Biotechnology, especially those related to the new, emerging fields of interest: White Biotechnology and Bioenergy.The journal reflects the modern and fast moving nature of engineering in life sciences and serves as a worldwide forum for the exchange of scientific information in this field, its interdisciplinary character supporting the transfer of scientific results of industrial biotechnology, as well as of environmental studies into technological processes. Concentrating on technology rather than on fundamental biological phenomena, it provides particularly useful insights into engineering applications.Rapid recent advances in genetic and metabolic engineering, systems biology, cell culture, tissue engineering and other biomedical applications have generated virtually unlimited potential for altering the capabilities of living systems expanding the scope of biotechnology, generating new applications for biological products and providing unprecedented ability to control life processes. A primary component of the mission of Engineering in Life Sciences is to facilitate the realization of this immense potential.All papers on microbiology, genetics, biochemistry, and applied environmental studies are technologically relevant, and there is a strong focus on bioprocess and biochemical engineering. Thus, the journal helps to drive advances in the covered fields, in terms of both research & development and the implementation of basic knowledge.

Enzyme and Microbial Technology is an international, peer-reviewed journal publishing original research and reviews, of biotechnological significance and novelty, on basic and applied aspects of the science and technology of processes involving the use of enzymes, micro-organisms, animal cells and plant cells.We especially encourage submissions on:Biocatalysis and the use of Directed Evolution in Synthetic Biology and BiotechnologyBiotechnological Production of New Bioactive Molecules, Biomaterials, Biopharmaceuticals, and BiofuelsNew Imaging Techniques and Biosensors, especially as applicable to Healthcare and Systems BiologyNew Biotechnological Approaches in Genomics, Proteomics and MetabolomicsMetabolic Engineering, Biomolecular Engineering and NanobiotechnologyManuscripts which report isolation, purification, immobilization or utilization of organisms or enzymes which are already well-described in the literature are not suitable for publication in EMT, unless their primary purpose is to report significant new findings or approaches which are of broad biotechnological importance. Similarly, manuscripts which report optimization studies on well-established processes are inappropriate. EMT does not accept papers dealing with mathematical modeling unless they report significant, new experimental data.

The journal European Food Research and Technology publishes state-of-the-art research papers and review articles on fundamental and applied food research. The journal's mission is the fast publication of high quality papers on front-line research, new and novel techniques and developing trends in such disciplines as chemistry and biochemistry; technology and molecular biotechnology; nutritional chemistry and toxicology; analytical and sensory methodologies and food physics. The Editors-in-Chief are T. Henle, Technische Universität Dresden, and T. Hofmann, Technische Universitat Munchen, Germany.

Lipids, fats and oils play an ever increasing role in many aspects of health, science and technology, e.g. health requirements, metabolism, tailor-made raw materials and renewable rescources. The European Journal of Lipid Science and Technology focusses on the scientific and geographical integration of this varied spectrum ranging from lipidomics, nutrition and health to analytics, biotechnology and process engineering as well as chemistry and physical chemistry. The journal is the official organ the European Federation for the Science and Technology of Lipids (Euro Fed Lipid). Highlights 2009:

The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Technology, Pharmaceutical Biotechnology and Biopharmaceutics.Topics covered include:• Drug and pro-drug design, drug stability and drug development• Development, formulation and manufacturing of pharmaceuticals and biopharmaceuticals• Physical pharmacy, drug delivery systems, controlled release systems and drug targeting• Biopharmaceutics• Pharmaceutical analysis and pharmaceutical packaging• Quality control, GMP and regulatory aspects• Medical devices"The Rules of 3"The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work:1. The paper must report on recent advances in pharmaceutical technology, biopharmaceutics and pharmaceutical biotechnology of major importance2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.3. The study described in the manuscript must represent a novel approachThe rules are also used as guidelines for the peer review of manuscripts. CLICK HERE to view the "Rules of 3".

Faraday Discussions covers a variety of topics in rapidly developing areas of the physical sciences, with a focus on physical chemistry and its interfaces with other scientific disciplines. The journal publishes the papers presented and a record of the questions, discussion and debate that took place at the corresponding Faraday Discussions meeting; and provides an important record of current international knowledge and opinions in the relevant field. Each Faraday Discussion covers a topic in a rapidly developing area of chemistry, and will be of interest to academic and industrial chemists across all areas of the chemical sciences. Topical coverage includes: • Spectroscopy • Dynamics • Kinetics • Statistical mechanics • Thermodynamics • Electrochemistry • Catalysis • Surface science • Quantum mechanics • Quantum computing • Machine learning • Polymers and soft matter • Materials • Quantum Materials • Nanoscience • Energy • Surfaces/interfaces • Biophysical chemistry • Atmospheric Chemistry • Astrochemistry

Other areas of strong interest are fermentation to improve foods, food ingredients, functional foods, and food waste remediation. In addition, articles addressing the topics of modern molecular and biochemical approaches to improving food safety are also published. Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.